Dextrose injections for failed back surgery syndrome: a consecutive case series
Patients with chronic low back pain, who do not respond to conservative treatment methods, generally undergo surgical revision operations, and sometimes an undesirable condition called failed back surgery syndrome (FBSS) may be inevitable. Hereby, dextrose is one of the regenerative methods that has gained popularity in the treatment of many musculoskeletal problems, and we aimed to present and evaluate the outcomes of 5% dextrose for the treatment of FBSS.
It has been designed as a consecutive case series. A total of 79 patients with FBSS, who had minimum 6 months of symptoms and did not respond to 3 months of conservative methods between May 2014 and March 2016, participated in the study. Prolotherapy injections were applied in posterior and lateral approaches. Visual Analog Scale (VAS) and Oswestry Disability Index (ODI) were used for the pre- and post-treatment evaluations. Patient satisfaction was assessed with using a 5-point Likert scale by phone contacting.
There was statistically significant difference between repeated VAS and ODI measurements.
These results may be the first step giving a lead to an undiscovered field. This treatment method should be kept in mind for FBSS patients before giving a decision of revision surgery.
KeywordsFailed back surgery syndrome FBSS Prolotherapy Dextrose Injection
We all thank Michael Yelland, Associate Professor, MD, and John Lyftogt, MD, for their respected contributions to the designation of this paper.
Compliance with ethical standards
Conflict of interest
İlker Solmaz, Serkan Akpancar, Aydan Örsçelik, Özlem Yener-Karasimav and Deniz Gül declare that they have no conflict of interest.
- 5.Choi HS, Chi EH, Kim MR et al (2014) Demographic characteristics and medical service use of failed back surgery syndrome patients at an integrated treatment hospital focusing on complementary and alternative medicine: a retrospective review of electronic medical records. Evid Based Complement Altern Med 2014:714389PubMedPubMedCentralGoogle Scholar
- 9.Tronnier VM, Eldabe S, Franke J, Huygen F, de Andres Rigoard P, Ares J et al (2018) The appropriate management of persisting pain after spine surgery: a European panel study with recommendations based on the RAND/UCLA method. Eur Spine J 28(1):31–45. https://doi.org/10.1007/s00586-018-5711-0 CrossRefPubMedGoogle Scholar
- 12.Akpancar S, Seven MM, Tuzun HY et al (2017) Current concepts of prolotherapy in orthopedic surgery. Arch Trauma Res 6(2):e40447Google Scholar
- 15.Di Paolo S, Gesualdo L, Ranieri E, Grandaliano G, Schena FP (1996) High glucose concentration induces the overexpression of transforming growth factor-beta through the activation of a platelet-derived growth factor loop in human mesangial cells. Am J Pathol. 149(6):2095–2106PubMedPubMedCentralGoogle Scholar
- 16.Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F et al (1999) Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem. 274(9):5830–5834CrossRefPubMedGoogle Scholar
- 18.Lyftogt J (2008) Pain conundrums: which hypothesis? Central nervous system sensitization versus peripheral nervous system autonomy. Aust Musculoskelet Med 13(2):72Google Scholar
- 22.Dagenais S, Yelland MJ, Del Mar C, Schoene ML (2007) Prolotherapy injections for chronic low-back pain. Cochrane Database Syst Rev. 18(2):CD004059.Google Scholar
- 24.Hackett GS, Hemwall GA, Montgomery GA (1993) Ligament and tendon relaxation treated by prolotherapy, 5th edn. Gustav A. Hemwall, Oak ParkGoogle Scholar
- 26.Jamieson S (2004) Likert scales: how to (ab)use them. Med Educ 38(12):1217–1218Google Scholar
- 41.Kim MY, Na YM, Moon JH (1997) Comparison on treatment effects of dextrose water, saline, and lidocaine for trigger point injection. J Korean Acad Rehabil Med 21(5):967–973Google Scholar
- 44.Clemente CD (1985) Gray’s Anatomy, 30th edn. Lea & Febiger, PhiladelphiaGoogle Scholar